MORC2 gene mutation study for nerve and brain conditions
Treatments studied
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study looks at how changes in the MORC2 gene relate to nerve or brain development problems. It may help doctors better understand these conditions and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed change (mutation) in the MORC2 gene linked to nerve issues or learning difficulties.
- You have had or can have a nerve test called an EMG.
- You are covered by a national health insurance or similar plan.
- You agree to provide a blood or tissue sample for testing.
- If you are a minor, your parents or guardians must agree for you.
- You do not have any other known genetic cause for your nerve or brain condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Charcot-Marie-Tooth disease (CMT) or related inherited nerve conditions change over time. It may help researchers better understand what to expect and guide future treatments.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without nerve disease. The goal is to better understand different CMT types and how symptoms and nerve test results change over time.
This study looks at how nerves work and their structure in people with Charcot-Marie-Tooth disease, CIDP, or anti-MAG neuropathy. It may help doctors better understand these conditions.
This study is looking at people with inherited (genetic) neurological conditions, as well as their family members, to better understand these diseases. Participants will receive a thorough evaluation, which may help with diagnosis and research.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
This study is building a registry (a group record) of people with morphea and collecting DNA samples to help researchers learn more about the condition. It may help by improving understanding of causes, patterns, and future treatments.
Hear when a new Charcot-Marie-Tooth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.